"Premier cataract and LASIK eye center located in the midtown area of Nashville, TN. In addition to LASIK, PRK, and SMILE, we offer treatment options for keratoconus, glaucoma, and dry eye."

During the past decade, Wang Vision Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wang Vision Institute" are "Corneal Ectasia" (1 trials), "Keratoconus" (1 trials) and "Presbyopia" (1 trials). Many other conditions were trialed in "Wang Vision Institute" in a lesser frequency.

Most popular intervention types in "Wang Vision Institute" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "KXL System (15 mW/cm2)" (1 trials), "KXL System (30 mW/cm2)" (1 trials), "KXL System (45 mW/cm2)" (1 trials), "PresVIEW Scleral Implants" (1 trials) and "riboflavin ophthalmic solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wang Vision Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wang Vision Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Wang Vision Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wang Vision Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".